The treatment of anti-phospholipid syndrome: A comprehensive clinical approach
- 1 June 2018
- journal article
- research article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 90, 1-27
Abstract
No abstract availableKeywords
This publication has 278 references indexed in Scilit:
- Antiphospholipid Antibodies in StillbirthObstetrics & Gynecology, 2013
- The Hyperferritinemic Syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndromeBMC Medicine, 2013
- Effect of prednisone, aspirin, low molecular weight heparin and intravenous immunoglobulin on outcome of pregnancy in women with antiphospholipid syndromeExperimental and Therapeutic Medicine, 2012
- Primary anti-phospholipid syndrome: any role for serum complement levels in predicting pregnancy complications?Rheumatology, 2012
- Effect of Low Molecular Weight Heparins (LMWHs) on antiphospholipid Antibodies (aPL) – Mediated Inhibition of Endometrial AngiogenesisPLOS ONE, 2012
- Hydroxychloroquine reduces binding of antiphospholipid antibodies to syncytiotrophoblasts and restores annexin A5 expressionAmerican Journal of Obstetrics and Gynecology, 2011
- High positive antibody titers and adverse pregnancy outcome in women with antiphospholipid syndromeActa Obstetricia et Gynecologica Scandinavica, 2011
- Hydroxychloroquine protects the annexin A5 anticoagulant shield from disruption by antiphospholipid antibodies: evidence for a novel effect for an old antimalarial drugBlood, 2010
- Combination of heparin and aspirin is superior to aspirin alone in enhancing live births in patients with recurrent pregnancy loss and positive anti-phospholipid antibodies: a meta-analysis of randomized controlled trials and meta-regressionRheumatology, 2009
- Hydroxychloroquine directly reduces the binding of antiphospholipid antibody–β2-glycoprotein I complexes to phospholipid bilayersBlood, 2008